Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  16 (2024)
Volume  15 (2023)
Volume  14 (2022)
Volume  13 (2021)
Volume  12 (2020)
Volume  11 (2019)
Volume  10 (2018)
Volume  9 (2017)
Volume  8 (2016)
Volume  7 (2015)
Volume  6 (2014)
Volume  5 (2013)
Volume  4 (2012)
Volume  3 (2011)
Volume  2 (2010)
Volume  1 (2009)
Related articles

VOLUME 15 , ISSUE 6 ( November-December, 2023 ) > List of Articles

RESEARCH ARTICLE

β-HCG and PAAP-A Levels during First Trimester as a Predictor of Gestational Hypertension and Growth-restricted Fetus

Rahul Bhagchand Chavan, Yogesh Gadekar, Vaibhav Khairnar, Meenakshi Pawar

Keywords : β-human chorionic gonadotropin, First trimester, Gestational hypertension, Pregnancy-associated plasma protein-A, Preeclampsia, Pregnancy complications

Citation Information : Chavan RB, Gadekar Y, Khairnar V, Pawar M. β-HCG and PAAP-A Levels during First Trimester as a Predictor of Gestational Hypertension and Growth-restricted Fetus. J South Asian Feder Obs Gynae 2023; 15 (6):737-741.

DOI: 10.5005/jp-journals-10006-2366

License: CC BY-NC 4.0

Published Online: 04-12-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Objective: The aim of this study is to study the association between abnormal serum analytes [pregnancy-associated plasma protein-A and β-human chorionic gonadotropin (β-HCG)] and the development of gestational hypertension (HTN) and intrauterine growth restriction (IUGR). Methods: A prospective observational study was carried out at ANC clinic of a hospital over a period of 18 months starting from January 2021 to June 2022. The ethical clearance was obtained from ethics committee of the institute. A total of 150 singleton pregnant women registered in the first trimester between 11 and 13.6 weeks were included in the study. The anthropometric measurements like height and weight were recorded and body mass index (BMI) was calculated. Results: Out of 17 subjects with low β-HCG, 2 (11.8%) developed gestational HTN, 2 (11.8%) developed IUGR, 2 (11.8%) developed both gestational HTN and IUGR, and 11 (64.7%) had no complications. Among subjects with normal β-HCG, 13 (10.3%) developed gestational HTN, 4 (3.2%) developed IUGR, 6 (4.8%) developed both gestational HTN and IUGR, and 103 (81.7%) had no complications. Among seven subjects with high βHCG level, two (28.6%) developed gestational HTN, two developed both gestational HTN and IUGR, and three (4.9%) had no complications. The result of Chi-square test indicated a significant association of gestational HTN and IUGR with the level of β-HCG (p < 0.05). Conclusion: The levels of β-HCG and PAAP-A during first trimester are significantly associated with the obstetric complications. Hence, in along with the routine check-ups and screenings, the levels of β-HCG and PAAP-A during first trimester might improve the chances of early identification of development of gestational HTN and IUGR.

HTML PDF Share
  1. Panda S, Das R, Sharma N, et al. Maternal and perinatal outcomes in hypertensive disorders of pregnancy and factors influencing it: A prospective hospital-based study in Northeast India. Cureus 2021;13(3):e13982. DOI: 10.7759/cureus.13982.
  2. Pal A, Bhattacharyya R, Adhikari S, et al. Eclampsia-scenario in a hospital: A ten years study. Bangladesh Med Res Counc Bull 2011;37(2):66–70. DOI: 10.3329/bmrcb.v37i2.8437.
  3. Cowans NJ, Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn 2007;27(3):264–271. DOI: 10.1002/pd.1665.
  4. Wu G, Bazer FW, Wallace JM, et al. Board-invited review: Intrauterine growth retardation: Implications for the animal sciences. J Anim Sci 2006;84(9):2316–2337. DOI: 10.2527/jas.2006-156.
  5. Gagnon A, Wilson RD, Society of Obstetricians and Gynaecologists of Canada Genetics Committee. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can 2008;30(10):918–932. DOI: 10.1016/S1701-2163(16)32973-5.
  6. Yu CM, Lin H, Yang H, et al. Progression of systolic abnormalities in patients with ‘isolated’ diastolic heart failure and diastolic dysfunction. Circulation 2002;105(10):1195–201. DOI: 10.1161/hc1002.105185.
  7. Bischof P, Schindler AM, Urner F, et al. Pregnancy-associated plasma protein-A (PAPP-A): Concentration in uterine fluid and immunohistochemical localization in the endometrium. Br J Obstet Gynaecol 1984;91(9):863–869. DOI: 10.1111/j.1471-0528.1984.tb03698.x.
  8. Lin TM, Galbert SP, Kiefer D, et al. Characterization of four human pregnancy-associated plasma proteins. Am J Obstet Gynecol 1974;118(2):223–236. DOI: 10.1016/0002-9378(74)90553-5.
  9. Papamichail M, Fasoulakis Z, Daskalakis G, et al. Importance of Low Pregnancy Associated Plasma Protein-A (PAPP-A) Levels During the First Trimester as a Predicting Factor for Adverse Pregnancy Outcomes: A Prospective Cohort Study of 2636 Pregnant Women. Cureus2022 [cited 2023];14(11):e31256. DOI: 10.7759/cureus.31256. Available from: https://www.cureus.com/articles/118403-importance-of-low-pregnancy-associated-plasma-protein-a-papp-a-levels-during-the-first-trimester-as-a-predicting-factor-for-adverse-pregnancy-outcomes-a-prospective-cohort-study-of-2636-pregnant-women.
  10. Fialova L, Malbohan IM. Pregnancy-associated plasma protein A (PAPP-A): Theoretical and clinical aspects. Bratisl Lek Listy 2002;103(6):194–205. PMID: 12448565.
  11. Betz D, Fane K. Human chorionic gonadotropin. In: StatPearls [Internet]. StatPearls Publishing: Florida; 2022 [cited 2023]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK532950/.
  12. Póvoa A, Xavier P, Matias A, et al. First trimester β-hCG and estradiol levels in singleton and twin pregnancies after assisted reproduction. J Perinat Med 2018;46(8):853–856. DOI: 10.1515/jpm- 2017-0132.
  13. Dugoff L, Hobbins JC, Malone FD, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004;191(4):1446–1451. DOI: 10.1016/j.ajog.2004.06.052.
  14. Ong CY, Liao AW, Spencer K, et al. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000;107(10):1265–1270. DOI: 10.1111/j.1471-0528.2000. tb11618.x.
  15. Goetzinger KR, Singla A, Gerkowicz S, et al. The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders. Am J Obstet Gynecol 2009;201(4):412.e1-e6. DOI: 10.1016/j.ajog.2009.07.016.
  16. Livrinova V, Petrov I, Samardziski I, et al. Clinical importance of low level of PAPP-A in first trimester of pregnancy: An obstetrical dilemma in chromosomally normal fetus. Open Access Maced J Med Sci 2019;7(9):1475–1479. DOI: 10.3889/oamjms.2019.384.
  17. Patil M, Panchanadikar TM, Wagh G. Variation of PAPP-A level in the first trimester of pregnancy and its clinical outcome. J Obstet Gynaecol India 2014;64(2):116–119. DOI: 10.1007/s13224-013-0481-4.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.